The city of Santa Ana, California, currently has 1 active clinical trials seeking participants for Dementia research studies.
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease
Recruiting
A phase 2, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of Allopregnanolone as a regenerative therapeutic for Alzheimer's disease.
Gender:
ALL
Ages:
Between 55 years and 80 years
Trial Updated:
05/06/2025
Locations: Syrentis Clinical Research, Santa Ana, California
Conditions: Alzheimer Dementia, Late Onset Alzheimer Disease, Neurodegenerative Diseases